Page last updated: 2024-08-18

pyrroles and angiotensin ii

pyrroles has been researched along with angiotensin ii in 67 studies

Research

Studies (67)

TimeframeStudies, this research(%)All Research%
pre-199010 (14.93)18.7374
1990's10 (14.93)18.2507
2000's24 (35.82)29.6817
2010's22 (32.84)24.3611
2020's1 (1.49)2.80

Authors

AuthorsStudies
McLeod, JD; Piper, PJ1
Fraser, R; Kenyon, CJ; Shepherd, RM1
Akiba, Y; Matsumoto, H; Nakano, H; Onodera, S; Osanai, S; Tobise, K1
Jahnecke, C; Kappes-Horn, K; Kramer, HJ; Meyer-Lehnert, H1
Davis, A; Holliwell, DL; Leenen, FH; Tasker, TC; von Nguyen, P1
Collier, JG; Webb, DJ1
Cook, NS; Quast, U1
Hironaka, T; Kim, S; Koh, E; Morimoto, S; Morita, R; Nabata, T; Ogihara, T; Onishi, T; Takamoto, S1
Ferrier, CP; Kurtz, A; Lehner, P; Pusterla, C; Saxenhofer, H; Shaw, SG; Weidmann, P1
Abrahamsson, T; Carlsson, L1
Cook, NS; Danzeisen, MC; Weir, SW1
Ahn, HS; Chiu, PJ; Sybertz, EJ; Tetzloff, G1
Buckingham, RE1
Kimura, BK; Phillips, MI1
Bentley, GA; Li, DM1
Bovy, PR; Chamberlain, TS; Collins, JT; Corpus, VM; Koepke, JP; McMahon, EG; Olins, GM; Palomo, MA; Reitz, DB; Smits, GJ1
Marthan, R; Savineau, JP1
Lu, GH; Major, TC; Panek, RL; Quin, J; Sircar, I; Winters, RT1
Komalavilas, P; Lincoln, TM1
Champion, HC; Kadowitz, PJ1
Arendshorst, WJ; Purdy, KE1
Bäumer, AT; Böhm, M; Konkol, C; Laufs, U; Müller, K; Nickenig, G; Sauer, H; Wassmann, S1
Böhm, M; Kilter, H; Konkol, C; Laufs, U; Nickenig, G; Wassmann, S1
Donnelly, R; Gray, S; Idris, I1
Hatta, T; Irie, H; Kameyama, H; Kusaba, T; Kuwahara, N; Matsubara, H; Narumiya, H; Sasaki, S; Takeda, K; Tamagaki, K1
Ahishali, B; Arican, N; Bilgic, B; Elmas, I; Kalayci, R; Kaya, M; Kucuk, M; Kudat, H; Uzun, H1
Bailey, M; Denver, R; Krum, H; Martin, J1
Armando, I; Bregonzio, C; Juorio, A; Macova, M; Pavel, J; Saavedra, JM; Sanchez-Lemus, E1
Boonstra, PW; Buikema, H; Morshuis, WJ; Nickenig, G; Plokker, HW; Six, AJ; van der Harst, P; van Gilst, WH; van Veldhuisen, DJ; Voors, AA; Wagenaar, LJ; Wassmann, S1
Covey, TR; Pawliszyn, J; Schneider, BB; Wang, Y1
Liu, YX; Sheng, L; Ye, P1
Hirase, T; Inoue, T; Node, K; Wang, D1
Bertone, C; Petricca, S; Rossi, F; Santiemma, V1
Hirano, H; Morishita, T; Nakashima, Y; Nakata, S; Ozumi, K; Sabanai, K; Sasaguri, Y; Shimokawa, H; Suda, O; Tanimoto, A; Tasaki, H; Tsutsui, M; Yamashita, T; Yanagihara, N1
Chen, P; Edwards, PA; Guo, AM; Scicli, AG; Trick, G1
Bech, JN; Holm, C; Paulsen, L; Pedersen, EB; Starklint, J1
Guo, J; Hu, Z; Wang, Q; Wu, J; Wu, X; Xu, J; Yin, Z1
Carvajal-González, G; Egido, J; Mezzano, S; Ortiz, A; Rodrigues Díez, R; Rodrigues-Díez, R; Rodríguez-Vita, J; Ruiz-Ortega, M; Sánchez-López, E; Selgas, R1
Braszko, JJ1
Bech, JN; Holst, LM; Paulsen, L; Pedersen, EB; Starklint, J1
Abraldes, JG; Arroyo, V; Bataller, R; Colmenero, J; Dominguez, M; Egido, J; Ginès, P; Moreno, M; Ramalho, F; Ramalho, LN; Ruiz-Ortega, M; Sancho-Bru, P1
Fukumoto, Y; Rashid, M; Seto, M; Shimokawa, H; Tawara, S; Yano, K1
Alonso, MJ; Briones, AM; Egido, J; García-Redondo, AB; Hernanz, R; Rodrigues-Díez, RR; Rodríguez-Criado, N; Ruiz-Ortega, M; Salaices, M1
Cui, W; Ibi, M; Ikami, K; Iwata, K; Kakehi, T; Katsuyama, M; Matsuno, K; Sasaki, M; Yabe-Nishimura, C; Zhu, K1
Fan, Y; Lu, JP; Ren, JH; Zhang, XS1
Kino, T; Matsuzawa, Y; Nishikawa, T; Omura, M; Saito, J; Suematsu, S1
Danser, AH; Kappers, MH; Sleijfer, S; Sluiter, W; van den Meiracker, AH; van Esch, JH1
Civantos, E; Egido, J; Lavoz, C; Mezzano, S; Ortiz, A; Rayego-Mateos, S; Rodrigues Díez, R; Rodrigues-Díez, R; Rodríguez-Vita, J; Ruiz-Ortega, M1
Bi, H; Chen, WA; Daugherty, A; Hong, B; Luo, Y; Wang, JA; Wang, Y; Xie, X; Zhang, S1
Aubin, MC; Carrier, M; Forcillo, J; Maltais, S; Perrault, LP; Shi, YF; Tardif, JC1
Chen, SC; Cheng, WP; Hung, HF; Shyu, KG; Wang, BW1
Brann, D; Cheng, H; Cheng, T; Li, S; Sun, Y; Wang, R; Wei, Z; Xu, H; Yang, F; Yuan, Y1
Amin, A; Badr El-Din, NK; Choi, SK; Kadowitz, P; Kevil, CG; Matrougui, K; Navar, LG; Osman-Elazeik, Y; Trebak, M1
Fukumoto, Y; Kudo, S; Liao, JK; Minami, T; Nochioka, K; Shiba, N; Shimokawa, H; Takai, Y; Tanaka, S; Williams, CL1
Bu, L; Cheng, Z; Dong, D; Huang, T; Shen, B; Tu, Y; Wan, L; Zhao, D1
Andersson, O; Bergh, N; Grote, L; Hrafnkelsdóttir, TJ; Saluveer, O; Widgren, BR1
Do e, Z; Fukumoto, Y; Kanazawa, M; Matsumoto, Y; Sato, A; Satoh, K; Shimizu, T; Shimokawa, H; Takahashi, K1
Bachelor, M; Carreno, FR; Cunningham, JT; Nedungadi, TP; Park, YH; Saxena, A1
Arévalo, M; Docherty, NG; Eleno, N; Fuentes-Calvo, I; Grande, MT; López-Novoa, JM; Pérez-Barriocanal, F; Rodríguez-Peña, AB1
Chen, Z; Ge, J; Ma, Y; Zou, Y1
Hui, L; Xiao-Ping, G; Yi, R1
Chen, J; Hu, YJ; Peng, DF; Tang, SY1
Liu, X; Sun, J; Wang, Q; Wang, R; Yu, K; Zhang, H1
Mishra, N; Nugent, WH; Strauss, JF; Walsh, SW1
Cho, SN; Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Kim, HS; Lin, MQ; Ryu, Y; Yu, SY1
Higashi, Y; Nagao, Y; Saito, M; Shimizu, S; Shimizu, T1
Heo, KS; Huynh, DTN; Jin, Y; Myung, CS1

Trials

8 trial(s) available for pyrroles and angiotensin ii

ArticleYear
Effects of the potassium channel activator, cromakalim, on arterial and cardiac responses to norepinephrine, angiotensin II, and isoproterenol in normotensive men.
    Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:6

    Topics: Adult; Angiotensin II; Benzopyrans; Cromakalim; Dose-Response Relationship, Drug; Hemodynamics; Humans; Isoproterenol; Male; Norepinephrine; Potassium Channels; Pyrroles; Stereoisomerism

1991
Stimulation of renin secretion by potassium-channel activation with cromakalim.
    European journal of clinical pharmacology, 1989, Volume: 36, Issue:5

    Topics: Adult; Angiotensin II; Benzopyrans; Blood Pressure; Cells, Cultured; Cromakalim; Heart Rate; Humans; Juxtaglomerular Apparatus; Male; Potassium Channels; Pyrroles; Renin; Stimulation, Chemical

1989
Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease.
    The American journal of cardiology, 2005, Nov-15, Volume: 96, Issue:10

    Topics: Aged; Angiotensin II; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; In Vitro Techniques; Male; Mammary Arteries; Middle Aged; Prospective Studies; Pyrroles; Treatment Outcome; Vasodilation

2005
Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:5

    Topics: Adult; Angiotensin II; Arginine Vasopressin; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diuresis; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Tubules; Male; Natriuresis; Natriuretic Peptide, Brain; Pyrroles; Renal Plasma Flow

2008
Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin-treated healthy men.
    Scandinavian journal of clinical and laboratory investigation, 2009, Volume: 69, Issue:3

    Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Kidney Function Tests; Lithium; Male; Natriuretic Peptide, Brain; Pyrroles; Renin; Sodium; Vasopressins

2009
Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors.
    Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Angiotensin II; Animals; Atorvastatin; Cells, Cultured; Cross-Over Studies; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Leukocytes; Male; Pravastatin; Pyrroles; Quinolines; rac1 GTP-Binding Protein; ras Proteins; Rats; Rats, Inbred WKY; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction

2009
Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 56, Issue:4

    Topics: Aged; Angiotensin II; Animals; Blood Pressure; Bradykinin; Carcinoma, Renal Cell; Cells, Cultured; Coronary Circulation; Endothelial Cells; Endothelin-1; Female; Gastrointestinal Stromal Tumors; Heart; Heart Rate; Humans; Hypertension; In Vitro Techniques; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Rats; Rats, Inbred WKY; Receptor Protein-Tyrosine Kinases; Renin; Sunitinib; Vascular Endothelial Growth Factor A

2010
Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.
    Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:7

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Atorvastatin; Biomarkers; Cardiomegaly; Cells, Cultured; Cholesterol; Cholesterol, LDL; Coronary Vessels; Cross-Over Studies; Cytoskeletal Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Guanine Nucleotide Exchange Factors; Heptanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Male; Mice; Mice, Knockout; Neuropeptides; Oxidative Stress; Phosphatidylinositol 3-Kinase; Pravastatin; Proto-Oncogene Proteins c-akt; Pyrroles; Quinolines; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; RNA Interference; Signal Transduction; Transfection

2013

Other Studies

59 other study(ies) available for pyrroles and angiotensin ii

ArticleYear
Effect of K+ channel-modulating drugs on the vasoconstrictor responses of leukotrienes C4, D4 and angiotensin II in the guinea-pig isolated perfused heart.
    British journal of pharmacology, 1992, Volume: 105, Issue:3

    Topics: Angiotensin II; Animals; Benzopyrans; Charybdotoxin; Cromakalim; Galanin; Guinea Pigs; Heart; In Vitro Techniques; Male; Myocardium; Nitroglycerin; Peptides; Potassium Channels; Pyrroles; Radioimmunoassay; Scorpion Venoms; SRS-A; Thromboxane A2; Vasoactive Intestinal Peptide; Vasoconstriction; Vasodilator Agents

1992
Membrane permeability to K+ and the control of aldosterone synthesis: effects of valinomycin and cromakalim in bovine adrenocortical cells.
    Journal of molecular endocrinology, 1992, Volume: 9, Issue:2

    Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Benzopyrans; Cattle; Cell Membrane Permeability; Cromakalim; In Vitro Techniques; Ion Transport; Potassium; Pyrroles; Steroid 21-Hydroxylase; Valinomycin

1992
[Effect of potassium channel openers on hypoxic pulmonary vasoconstriction].
    Nihon Kyobu Shikkan Gakkai zasshi, 1992, Volume: 30, Issue:8

    Topics: Angiotensin II; Animals; Benzopyrans; Cromakalim; Guanidines; Hypoxia; In Vitro Techniques; Pinacidil; Potassium Channels; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasodilator Agents

1992
[Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells].
    Klinische Wochenschrift, 1991, Volume: 69 Suppl 24

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Bridged Bicyclo Compounds; Calcium; Calcium Channel Blockers; Calcium Channels; Culture Techniques; Dose-Response Relationship, Drug; Gallic Acid; Muscle, Smooth, Vascular; Pyrroles; Ramipril; Rats; Verapamil

1991
Vascular angiotensin conversion in humans.
    Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 10

    Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Forearm; Humans; Hypertension; Kinetics; Peptidyl-Dipeptidase A; Pyrroles; Ramipril; Reference Values; Regional Blood Flow; Renin

1986
In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 250, Issue:1

    Topics: Angiotensin II; Animals; Aorta; Benzopyrans; Blood Pressure; Cromakalim; Diazoxide; Glyburide; Heart Rate; In Vitro Techniques; Muscle, Smooth, Vascular; Norepinephrine; Portal Vein; Potassium Channels; Pyrroles; Rabbits; Rats; Rats, Inbred SHR; Rubidium; Vasoconstriction

1989
Effects of valinomycin on calcium mobilization in vascular smooth muscle cells induced by angiotensin II.
    Biochemical and biophysical research communications, 1989, Jul-14, Volume: 162, Issue:1

    Topics: Angiotensin II; Animals; Benzopyrans; Calcium; Cromakalim; Endothelium, Vascular; Ethers; Female; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Ionomycin; Ionophores; Monensin; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Pyrroles; Rats; Valinomycin

1989
Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
    European journal of pharmacology, 1989, Jul-18, Volume: 166, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Disease; Creatine Kinase; Heart; In Vitro Techniques; Indomethacin; Male; Myocardium; Norepinephrine; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Saralasin

1989
Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine.
    British journal of pharmacology, 1988, Volume: 95, Issue:3

    Topics: Angiotensin II; Animals; Aorta; Benzopyrans; Calcium Channel Blockers; Cromakalim; Female; In Vitro Techniques; Isradipine; Male; Norepinephrine; Potassium Channels; Pyridines; Pyrroles; Rabbits; Rubidium; Vasodilator Agents

1988
Effects of BRL 34915, a putative K channel opener, on transmembrane 45Ca movements in rabbit aortic smooth muscle.
    European journal of pharmacology, 1988, Oct-18, Volume: 155, Issue:3

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Benzopyrans; Biological Transport, Active; Calcium; Cromakalim; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitroprusside; Norepinephrine; Potassium; Potassium Channels; Pyrroles; Rabbits; Tetraethylammonium Compounds; Vasoconstriction

1988
Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine.
    British journal of pharmacology, 1988, Volume: 93, Issue:3

    Topics: Angiotensin II; Animals; Benzopyrans; Blood Pressure; Cromakalim; Dose-Response Relationship, Drug; Female; Hypertension; Infusions, Intravenous; Nifedipine; Norepinephrine; Phenylephrine; Pyrroles; Rats; Rats, Inbred SHR; Vasoconstriction; Vasopressins

1988
Levels of brain angiotensin in the spontaneously hypertensive rat and treatment with ramiprilat.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1986, Volume: 4, Issue:6

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Brain; Hypertension; Pyrroles; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Spinal Cord

1986
Reflex vascular responses to vasoactive substances.
    European journal of pharmacology, 1970, Volume: 12, Issue:2

    Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Atropine; Blood Vessels; Carotid Sinus; Cats; Chemoreceptor Cells; Constriction; Denervation; Desipramine; Dextroamphetamine; Dilatation; Dopamine; Epinephrine; Female; Ganglionic Blockers; Hindlimb; Histamine; Histamine H1 Antagonists; Male; Nerve Endings; Norepinephrine; Perfusion; Pressoreceptors; Pyrroles; Reflex; Sympathetic Nervous System; Tachyphylaxis; Tripelennamine; Vagotomy; Vagus Nerve; Veratrine

1970
Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists.
    Journal of medicinal chemistry, 1993, Jan-08, Volume: 36, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding Sites; Female; Male; Muscle, Smooth, Vascular; Pyrroles; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship; Uterus

1993
Effect of cromakalim on KCl-, noradrenaline- and angiotensin II-induced contractions in the rat pulmonary artery.
    Pulmonary pharmacology, 1993, Volume: 6, Issue:1

    Topics: Angiotensin II; Animals; Benzopyrans; Bronchodilator Agents; Cromakalim; Glyburide; In Vitro Techniques; Isometric Contraction; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phentolamine; Potassium Chloride; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar; Tetraethylammonium Compounds

1993
Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists.
    Journal of medicinal chemistry, 1993, Jun-11, Volume: 36, Issue:12

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Membrane; Imidazoles; Liver; Male; Models, Molecular; Molecular Conformation; Molecular Structure; Pyrroles; Rabbits; Rats; Receptors, Angiotensin; Structure-Activity Relationship

1993
Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta.
    The Journal of biological chemistry, 1996, Sep-06, Volume: 271, Issue:36

    Topics: Alkaloids; Angiotensin II; Animals; Aorta; Calcium Channels; Carbazoles; Colforsin; Cyclic AMP; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Indoles; Inositol 1,4,5-Trisphosphate Receptors; Male; Nitroprusside; Phosphorylation; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Thionucleotides; Time Factors

1996
Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism.
    The American journal of physiology, 1997, Volume: 273, Issue:1 Pt 2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Albuterol; Alprostadil; Analysis of Variance; Angiotensin II; Animals; Benzopyrans; Blood Pressure; Bradykinin; Cats; Cromakalim; Endothelium, Vascular; Female; Glyburide; Heart Rate; Hindlimb; Hydrazines; Isradipine; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitrogen Oxides; Nitroprusside; Norepinephrine; Penicillamine; Prostaglandin Endoperoxides, Synthetic; Pyrroles; S-Nitroso-N-Acetylpenicillamine; Substance P; Tetraethylammonium; Tetraethylammonium Compounds; Thromboxane A2; Vasoactive Intestinal Peptide; Vasodilation; Vasodilator Agents

1997
Iloprost inhibits inositol-1,4,5-trisphosphate-mediated calcium mobilization stimulated by angiotensin II in cultured preglomerular vascular smooth muscle cells.
    Journal of the American Society of Nephrology : JASN, 2001, Volume: 12, Issue:1

    Topics: Angiotensin II; Animals; Calcium; Calcium Channels, L-Type; Calcium-Transporting ATPases; Carbazoles; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Iloprost; Indoles; Inositol 1,4,5-Trisphosphate; Kidney Glomerulus; Milrinone; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Pyrroles; Rats; Thapsigargin

2001
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
    Molecular pharmacology, 2001, Volume: 59, Issue:3

    Topics: Angiotensin II; Animals; Atorvastatin; Cells, Cultured; Down-Regulation; Free Radicals; Gene Expression; GTP Phosphohydrolases; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle, Smooth, Vascular; Protein Prenylation; Pyrroles; rac1 GTP-Binding Protein; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA Stability; RNA, Messenger

2001
Impact of HMG CoA reductase inhibition on small GTPases in the heart.
    Cardiovascular research, 2002, Volume: 53, Issue:4

    Topics: Angiotensin II; Animals; Atorvastatin; Atrial Natriuretic Factor; Cardiac Myosins; Cardiomegaly; Cell Membrane; Cells, Cultured; Gene Expression Regulation; GTP Phosphohydrolases; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Myocardium; Myosin Light Chains; Pyrroles; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; RNA, Messenger; Simvastatin

2002
Protein kinase C-beta inhibition and diabetic microangiopathy: effects on endothelial permeability responses in vitro.
    European journal of pharmacology, 2004, Feb-06, Volume: 485, Issue:1-3

    Topics: Angiotensin II; Capillary Permeability; Diabetic Angiopathies; Endothelium, Vascular; Enzyme Inhibitors; Glucose; Humans; Mesylates; Protein Kinase C; Protein Kinase C beta; Pyrroles

2004
HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells.
    Cardiovascular research, 2004, Nov-01, Volume: 64, Issue:2

    Topics: Amides; Analysis of Variance; Angiotensin II; Atorvastatin; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Glucuronidase; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules; Klotho Proteins; Membrane Proteins; Pyridines; Pyrroles; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; rhoA GTP-Binding Protein; RNA, Messenger

2004
Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats.
    Brain research, 2005, May-03, Volume: 1042, Issue:2

    Topics: Angiotensin II; Animals; Atorvastatin; Blood-Brain Barrier; Heptanoic Acids; Hypertension; Male; NG-Nitroarginine Methyl Ester; Permeability; Pyrroles; Rats; Rats, Wistar

2005
In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling.
    Clinical and experimental pharmacology & physiology, 2005, Volume: 32, Issue:9

    Topics: Angiotensin II; Animals; Atorvastatin; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Extracellular Matrix; Fibroblasts; Heart; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Myocardium; Procollagen; Pyrroles; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling

2005
A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:6

    Topics: Amphibian Proteins; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Autoradiography; Behavior, Animal; Benzimidazoles; Benzodiazepines; Biphenyl Compounds; Cerebral Cortex; Disease Models, Animal; Flunitrazepam; GABA Modulators; In Situ Hybridization; Male; Maze Learning; Peptide Hormones; Peptides; Protein Binding; Pyrimidines; Pyrroles; Rats; Receptor, Angiotensin, Type 2; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Social Isolation; Stress, Physiological; Tetrazoles; Tyrosine 3-Monooxygenase

2006
High-performance SPME/AP MALDI system for high-throughput sampling and determination of peptides.
    Analytical chemistry, 2005, Dec-15, Volume: 77, Issue:24

    Topics: Angiotensin I; Angiotensin II; Bradykinin; Peptides; Polymers; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Microextraction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2005
[Atorvastatin upregulates the expression of PPAR alpha/gamma and inhibits the hypertrophy of cardiac myocytes in vitro].
    Zhonghua xin xue guan bing za zhi, 2005, Volume: 33, Issue:12

    Topics: Angiotensin II; Animals; Atorvastatin; Cardiomegaly; Cells, Cultured; Gene Expression Regulation; Heptanoic Acids; Myocytes, Cardiac; PPAR alpha; PPAR-beta; Pyrroles; Rats; Rats, Wistar; Up-Regulation

2005
Atorvastatin inhibits angiotensin II-induced T-type Ca2+ channel expression in endothelial cells.
    Biochemical and biophysical research communications, 2006, Aug-25, Volume: 347, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atorvastatin; Benzimidazoles; Biphenyl Compounds; Calcium Channels, T-Type; Cells, Cultured; Endothelial Cells; Flavonoids; Gene Expression; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Microscopy, Fluorescence; Pyrroles; ras Proteins; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetrazoles; Vasoconstrictor Agents

2006
Ghrelin inhibits angiotensin II-induced migration of human aortic endothelial cells.
    Atherosclerosis, 2007, Volume: 192, Issue:2

    Topics: Adenine; Adenylyl Cyclase Inhibitors; Angiotensin II; Aorta; Carbazoles; Cell Movement; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Endothelium, Vascular; Ghrelin; Humans; Indoles; Oligopeptides; Peptide Hormones; Proto-Oncogene Proteins c-akt; Pyrroles

2007
Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway.
    Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:1

    Topics: Angiotensin II; Animals; Atorvastatin; Cells, Cultured; Endothelin-1; Gene Expression Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mevalonic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oncogene Protein v-akt; Pyrroles; Rats; Rats, Sprague-Dawley; Up-Regulation

2007
Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2007, Volume: 293, Issue:4

    Topics: Acetophenones; Acetylcysteine; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Imidazoles; Indoles; Leukostasis; Losartan; Male; NADPH Oxidases; Pyridines; Pyrroles; Rats; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Retinal Diseases; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents

2007
Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
    European journal of pharmacology, 2008, Jul-28, Volume: 589, Issue:1-3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Cattle; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Injections, Intravenous; Liver; Losartan; Male; Protein Binding; Pyrroles; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Time Factors; Triazoles; Vasoconstriction

2008
Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways.
    Pharmaceutical research, 2008, Volume: 25, Issue:10

    Topics: Angiotensin II; Atorvastatin; Cell Line; Cell Transdifferentiation; Connective Tissue Growth Factor; Epithelial Cells; Fibrosis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney Tubules, Proximal; Mitogen-Activated Protein Kinase Kinases; Phenotype; Protein Kinase Inhibitors; Pyrroles; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Simvastatin; Time Factors; Transfection

2008
Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2009, Volume: 19, Issue:2

    Topics: Angiotensin II; Animals; Anxiety; Avoidance Learning; Cognition; Data Interpretation, Statistical; Dopamine Antagonists; Exploratory Behavior; Form Perception; Injections, Intraventricular; Male; Maze Learning; Mental Recall; Motor Activity; Pyridines; Pyrroles; Rats; Rats, Wistar; Receptors, Dopamine D4; Recognition, Psychology

2009
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
    American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 296, Issue:2

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atorvastatin; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Chemical and Drug Induced Liver Injury; Collagen Type I; Collagen Type I, alpha 1 Chain; Disease Models, Animal; Hepatic Stellate Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Infusion Pumps, Implantable; Intercellular Adhesion Molecule-1; Interleukin-6; Liver; Male; Oxidative Stress; Pyrroles; Rats; Rats, Wistar; Transforming Growth Factor beta1

2009
Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:1

    Topics: Angiotensin II; Animals; Atorvastatin; Blood Pressure; Blotting, Western; Cells, Cultured; Collagen; Elasticity; Extracellular Matrix; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Malondialdehyde; Mesenteric Arteries; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type III; Oxidative Stress; Pyrroles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Superoxide Dismutase; Superoxides; Vasoconstrictor Agents

2009
NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models.
    Journal of pharmacological sciences, 2009, Volume: 111, Issue:3

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Apolipoproteins E; Atorvastatin; Blood Pressure; Blotting, Western; Dietary Fats; Ethidium; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Isoenzymes; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Nitric Oxide Synthase; Pyrroles; rac1 GTP-Binding Protein; Reverse Transcriptase Polymerase Chain Reaction

2009
Atorvastatin protects against angiotensin II-induced injury and dysfunction in human umbilical vein endothelial cells through bradykinin 2 receptors.
    Journal of cardiovascular pharmacology, 2010, Volume: 56, Issue:2

    Topics: Angiotensin II; Apoptosis; Atorvastatin; Cell Line; Endothelial Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nitric Oxide Synthase Type III; Pyrroles; Receptor, Bradykinin B2; Umbilical Veins

2010
Effect of atorvastatin on aldosterone production induced by glucose, LDL or angiotensin II in human renal mesangial cells.
    Arzneimittel-Forschung, 2010, Volume: 60, Issue:7

    Topics: Aldosterone; Angiotensin II; Anticholesteremic Agents; Atorvastatin; Cytochrome P-450 CYP11B2; Diabetic Nephropathies; Glucose; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Mesangial Cells; Pyrroles; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2010
Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process.
    PloS one, 2010, Nov-30, Volume: 5, Issue:11

    Topics: Angiotensin II; Animals; Aorta; Atorvastatin; Blotting, Western; Cells, Cultured; Fibrosis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrroles; Rats; Rats, Wistar; Signal Transduction; Simvastatin; Smad Proteins; Transforming Growth Factor beta; Vasoconstrictor Agents

2010
Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms.
    Atherosclerosis, 2011, Volume: 217, Issue:1

    Topics: Angiotensin II; Animal Feed; Animals; Anti-Inflammatory Agents; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Atorvastatin; Blood Pressure; Fluorobenzenes; Gene Expression Regulation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mice; Mice, Inbred C57BL; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides

2011
Atorvastatin worsens left ventricular diastolic dysfunction and endothelial dysfunction of epicardial coronary arteries in normocholesterolemic porcine with left ventricular hypertrophy.
    Journal of cardiovascular pharmacology, 2011, Volume: 58, Issue:3

    Topics: Angiotensin II; Animals; Aorta; Atorvastatin; Coronary Vessels; Cyclic GMP; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Echocardiography; Endothelium, Vascular; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Nitrates; Nitrites; Pyrroles; Random Allocation; Swine; Vasodilation; Ventricular Dysfunction, Left

2011
Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells.
    Clinical science (London, England : 1979), 2012, Volume: 122, Issue:1

    Topics: Angiotensin II; Anticholesteremic Agents; Atorvastatin; Blotting, Western; Cell Movement; Cell Proliferation; Cells, Cultured; Coronary Vessels; Heptanoic Acids; Humans; JNK Mitogen-Activated Protein Kinases; Leptin; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Pyrroles; rac1 GTP-Binding Protein; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Vasoconstrictor Agents

2012
A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Actins; Angiotensin II; Animals; Cell Differentiation; Collagen Type I; Collagen Type III; Lung; Male; Myofibroblasts; Oligopeptides; Pyrazoles; Pyrroles; Rats; Rats, Wistar; Receptors, Transforming Growth Factor beta; RNA, Messenger; Silicosis; Transforming Growth Factor beta1

2012
Sodium nitrite therapy rescues ischemia-induced neovascularization and blood flow recovery in hypertension.
    Pflugers Archiv : European journal of physiology, 2012, Volume: 464, Issue:6

    Topics: Allopurinol; Angiotensin II; Animals; Arterial Pressure; Capillaries; Cyclic AMP; Cyclic GMP; Femoral Artery; Hindlimb; Hypertension; Indoles; Ischemia; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow; Sodium Nitrite; Xanthine Dehydrogenase

2012
MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2013, Volume: 31, Issue:6

    Topics: Angiotensin II; Animals; Anticholesteremic Agents; Atorvastatin; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Down-Regulation; Heptanoic Acids; Male; Mice; MicroRNAs; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Oligonucleotides, Antisense; Phosphoric Monoester Hydrolases; PTEN Phosphohydrolase; Pyrroles; Rats

2013
Acute vascular effects of atorvastatin in hypertensive men: a pilot study.
    Scandinavian cardiovascular journal : SCJ, 2013, Volume: 47, Issue:5

    Topics: Angiotensin II; Atorvastatin; Endothelium, Vascular; Forearm; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Pilot Projects; Pyrroles; Regional Blood Flow; Vasoconstriction; Vasodilation

2013
Combination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Amlodipine; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apoptosis; Atorvastatin; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Drug Therapy, Combination; Enzyme Activation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipids; Male; Matrix Metalloproteinases; Mice; Mice, Knockout; Pyrroles; rho-Associated Kinases

2013
Angiotensin II induces membrane trafficking of natively expressed transient receptor potential vanilloid type 4 channels in hypothalamic 4B cells.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2014, Oct-15, Volume: 307, Issue:8

    Topics: Angiotensin II; Animals; Calcium; Cell Line; Cells, Cultured; Hypothalamus; Leucine; Membrane Microdomains; Morpholines; Protein Transport; Pyrroles; Rats; Receptor, Angiotensin, Type 1; Signal Transduction; src-Family Kinases; Sulfonamides; TRPV Cation Channels

2014
Effect of angiotensin II and small GTPase Ras signaling pathway inhibition on early renal changes in a murine model of obstructive nephropathy.
    BioMed research international, 2014, Volume: 2014

    Topics: Angiotensin II; Animals; Atorvastatin; Disease Models, Animal; Fibrosis; Heptanoic Acids; Humans; Kidney; Kidney Diseases; Mice; Monomeric GTP-Binding Proteins; Pyrroles; Receptor, Angiotensin, Type 1; Signal Transduction; Ureteral Obstruction

2014
Atorvastatin represses the angiotensin 2-induced oxidative stress and inflammatory response in dendritic cells via the PI3K/Akt/Nrf 2 pathway.
    Oxidative medicine and cellular longevity, 2014, Volume: 2014

    Topics: Angiotensin II; Animals; Anticholesteremic Agents; Atorvastatin; Bone Marrow Cells; Cell Proliferation; Cells, Cultured; Cytokines; Dendritic Cells; Heptanoic Acids; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyrroles; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; T-Lymphocytes; Tumor Necrosis Factor-alpha

2014
Atorvastatin prevents angiotensin II-induced high permeability of human arterial endothelial cell monolayers via ROCK signaling pathway.
    Biochemical and biophysical research communications, 2015, Mar-27, Volume: 459, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Arteries; Atorvastatin; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Heptanoic Acids; Humans; Lim Kinases; Permeability; Phosphorylation; Pyrroles; rho-Associated Kinases; Signal Transduction; Zonula Occludens-1 Protein

2015
Protective effects of valsartan and benazepril combined with atorvastatin on cardiorenal syndrome in rats.
    European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:5

    Topics: Angiotensin II; Animals; Atorvastatin; Benzazepines; C-Reactive Protein; Cardio-Renal Syndrome; Case-Control Studies; Drug Synergism; Heptanoic Acids; Lipids; Male; Natriuretic Peptide, Brain; Proteinuria; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan

2015
Blockade of vascular endothelial growth factor-A/receptor 2 exhibits a protective effect on angiotensin-II stimulated podocytes.
    Molecular medicine reports, 2015, Volume: 12, Issue:3

    Topics: Angiotensin II; Animals; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Indoles; Mice; Microfilament Proteins; Phosphorylation; Podocytes; Protein Processing, Post-Translational; Pyrroles; Transcriptional Activation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2

2015
Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1.
    Reproductive sciences (Thousand Oaks, Calif.), 2016, Volume: 23, Issue:4

    Topics: Adult; Angiotensin II; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Matrix Metalloproteinase 1; Omentum; Organ Culture Techniques; Pre-Eclampsia; Pregnancy; Pyrroles; Quinazolines; Receptor, PAR-1; Vasoconstriction; Young Adult

2016
Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.
    Journal of hypertension, 2016, Volume: 34, Issue:11

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Cycle Proteins; Cell Nucleus; Cell Proliferation; Cells, Cultured; DNA; GATA6 Transcription Factor; Gene Expression; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Hypertension; Hypertrophy; Kidney; Male; Mice; Muscle, Smooth, Vascular; Phosphorylation; Pyrroles; Repressor Proteins; Vascular Remodeling

2016
Central angiotensin II type 1 receptor as a therapeutic target against frequent urination.
    Neurourology and urodynamics, 2019, Volume: 38, Issue:8

    Topics: Amphibian Proteins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Male; Peptide Hormones; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Telmisartan; Urination

2019
Inhibition of p90RSK is critical to abolish Angiotensin II-induced rat aortic smooth muscle cell proliferation and migration.
    Biochemical and biophysical research communications, 2020, 02-26, Volume: 523, Issue:1

    Topics: Angiotensin II; Animals; Aorta; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Rats; Ribosomal Protein S6 Kinases, 90-kDa; Structure-Activity Relationship; Wound Healing

2020